Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
Launched by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) · Nov 2, 1999
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meets criteria for alcohol abuse or dependence and post-traumatic stress disorder.
- • Laboratory tests for blood and urinalysis must be within normal limits.
- • Must be clearly motivated to obtain benefit from treatment and keep appointments for study visits and therapy sessions.
- • Females who use an acceptable method of birth control, are sterilized, or are at least 2 years post-menopausal.
- Exclusion Criteria:
- • Have a diagnosis of schizophrenia, bipolar affective disorder, dissociative identity disorder, eating disorder, substance dependence in the last 60 days.
- • Currently suicidal.
- • Medical reasons not to receive drug therapy.
- • Allergy or hypersensitivity to selective serotonin inhibitor antidepressants.
- • Significant hematological, endocrine, cardiovascular, renal, hepatic, neurological, or gastrointestinal disease.
- • Liver function test greater than 2 times the normal level
- • Require ongoing therapy with another psychoactive drug during the study period.
- • Females who are pregnant or lactating.
About National Institute On Alcohol Abuse And Alcoholism (Niaaa)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is a leading federal agency dedicated to advancing research on alcohol-related health issues and fostering a deeper understanding of alcohol use disorders. As part of the National Institutes of Health (NIH), NIAAA supports a diverse portfolio of clinical trials aimed at developing innovative prevention and treatment strategies for alcohol abuse and dependence. By collaborating with researchers, healthcare providers, and community organizations, NIAAA strives to translate scientific findings into effective public health initiatives, ultimately aiming to reduce the impact of alcohol on individuals and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials